Biocon shares rose after USFDA issues no observations on Bengaluru facility
Biocon shares on June 5 edged higher on the back of the USFDA issuing 'no observations' on the company's oral solid dosage formulations manufacturing facility at Bengaluru.
Written By: Zee Business Video Team